Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acipimox with Walking Exercise in Pre-diabetes
NCT03809793Completed
- Sponsor
- Liverpool John Moores University
- Start
- Jan 2020
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of acipimox in prediabetes (2 arms), sponsored by Liverpool John Moores University. Primary endpoint: Change in Insulin Sensitivity at 12 weeks. Started Jan 2020; status: completed.
02
Drugs
acipimox
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT03809793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03809793.